RE
WST icon

RBC Europe’s West Pharmaceutical WST Stock Holding History

RBC Europe’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$12K Hold
40
– – ﹤0.01% 480
2022
Q1 		$16K Hold
40
– – ﹤0.01% 483
2021
Q4 		$19K Sell
40
-101
-72% -$43.5K ﹤0.01% 464
2021
Q3 		$59.9K Buy
141
+20
+17% +$8.43K ﹤0.01% 538
2021
Q2 		$43.5K Buy
+121
New +$40K ﹤0.01% 623

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

RBC Europe's WST Position: Q2 2022 in Review

RBC Europe held its West Pharmaceutical (WST) position steady in Q2 2022 at 40 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

RBC Europe first reported a position in WST in Q2 2021 and has held it in 5 quarters since. The position peaked at $59.9K in Q3 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • RBC Europe held 40 shares of West Pharmaceutical worth $12K as of Q2 2022.
  • RBC Europe left its West Pharmaceutical share count unchanged in Q2 2022.
  • West Pharmaceutical made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #480 holding.
  • RBC Europe first reported a position in West Pharmaceutical in Q2 2021 and has held it in 5 quarters since.
  • RBC Europe's West Pharmaceutical position peaked at $59.9K in Q3 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.